02-Nov-2022
Download PDF
Solara Active
Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30 2022 amongst other matters.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
